Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of MEDI3250 (Q/LAIV) vs FluMist in Adults
NCT00860067Phase 3Completed
- Sponsor
- MedImmune
- Start
- Mar 2009
- Primary completion
- May 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of live attenuated influenza vaccine in influenza, sponsored by MedImmune. Started Mar 2009; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00860067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860067.